Advertisement
News
Advertisement

Medidata Solutions to Present at the Raymond James 34th Annual Institutional Investors Conference

Fri, 03/01/2013 - 8:30am
The Associated Press

NEW YORK--(BUSINESS WIRE)--Mar 1, 2013--Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical development solutions, today announced that Bryan Spielman, executive vice president of strategy and corporate development, and Cory Douglas, chief financial officer, will present at the Raymond James 34th Annual Institutional Investors Conference on March 6, 2013, at 8:40 a.m. EST in Orlando, FL.

A live audio webcast will be available on the “Investor” section of Medidata’s website at http://investor.mdsol.com. Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the “Investor” section of Medidata’s website at http://investor.mdsol.com for a limited time following the conference.

About Medidata Solutions Worldwide
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading